ARRB1 — Arrestin Beta 1

📖 Wiki Page

gene1388 wordssynced 2026-04-02

ARRB1 — Arrestin Beta 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Arrestin Beta 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ARRB1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Arrestin beta 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11q13.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[409](https://www.ncbi.nlm.nih.gov/gene/409)</td></tr>
<tr><td><strong>OMIM</strong></td><td>107940</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000141428</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P49407](https://www.uniprot.org/uniprot/P49407)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

...

ARRB1 — Arrestin Beta 1

Overview

Mermaid diagram (expand to render)

ARRB1 (Arrestin Beta 1), also known as beta-arrestin 1, is a member of the arrestin family of proteins that plays a crucial role in regulating G protein-coupled receptor (GPCR) signaling [1](https://pubmed.ncbi.nlm.nih.gov/15229605/). Arrestins bind to phosphorylated GPCRs, blocking further G protein coupling and promoting receptor internalization through clathrin-coated pits [2](https://doi.org/10.1016/j.tips.2019.07.001). Beyond receptor desensitization, ARRB1 serves as signaling scaffolds, activating pathways including MAPK, Akt, and PI3K [3](https://doi.org/10.1016/j.tcb.2020.03.005). In the nervous system, ARRB1 regulates neurotransmission, synaptic plasticity, and neuronal survival. Dysregulated arrestin signaling is implicated in neurodegenerative diseases and psychiatric disorders.

Gene and Protein Structure

The ARRB1 gene is located on chromosome 11q13.1 and encodes a 418-amino acid protein with a molecular weight of approximately 46 kDa. The protein adopts a typical arrestin fold:

N-terminal domain (residues 1-210):

Contains the receptor binding interface
Features a polar core that maintains inactive conformation
Undergoes conformational changes upon receptor binding

C-terminal domain (residues 211-418):

Contains the clathrin and AP2 binding sites
Functions in receptor internalization
Includes multiple serine/threonine phosphorylation sites

ARRB1 shares approximately 70% sequence identity with ARRB2 (arrestin beta 2), with the highest conservation in the central polar core and the C-terminal domain [4](https://doi.org/10.1016/j.jmb.2019.12.012).

Normal Function

GPCR Desensitization and Internalization

ARRB1 functions as a master regulator of GPCR signaling [5](https://doi.org/10.1016/j.pharmthera.2019.107402):

Receptor phosphorylation recognition: When GPCRs are activated, they are phosphorylated by G protein-coupled receptor kinases (GRKs). ARRB1 recognizes these phosphorylated receptors through multiple phosphate sensors in its N-terminal domain.

G protein uncoupling: Upon binding to phosphorylated receptors, ARRB1 undergoes a conformational change that blocks further G protein coupling, effectively terminating G protein-mediated signaling.

Internalization: ARRB1 recruits clathrin and adaptor protein complex AP2 to the receptor, promoting internalization through clathrin-coated pits. The C-terminal domain of ARRB1 contains clathrin box motifs that directly interact with clathrin.

Signaling Scaffold Function

Beyond desensitization, ARRB1 serves as a signaling scaffold [6](https://doi.org/10.1016/j.tcb.2020.03.005):

MAPK pathway activation: ARRB1 recruits components of the MAPK cascade (Raf, MEK, ERK) to activated receptors, enabling G protein-independent signaling. This is particularly important for β-adrenergic and angiotensin receptors.

Akt signaling: ARRB1 can activate Akt/PKB pathway through recruitment of PI3K, promoting cell survival and metabolic regulation.

β-catenin signaling: In some contexts, ARRB1 regulates β-catenin degradation through interaction with β-TrCP, affecting gene transcription and cell proliferation.

Neuronal Functions

In neurons, ARRB1 performs several critical functions:

Receptor regulation: ARRB1 regulates neurotransmitter receptors including dopamine, serotonin, glutamate, and GABA receptors. This controls the strength and duration of synaptic signaling.

Synaptic plasticity: Through regulation of AMPA receptor trafficking and signaling, ARRB1 influences long-term potentiation (LTP) and long-term depression (LTD), cellular correlates of learning and memory [7](https://doi.org/10.1016/j.neuron.2020.02.015).

Dendritic spine morphology: ARRB1 affects spine shape and density through regulation of cytoskeletal dynamics and receptor signaling at excitatory synapses.

Neuronal survival: ARRB1-mediated Akt signaling provides pro-survival signals that protect neurons from various insults.

Expression Pattern

ARRB1 is widely expressed throughout the brain:

Hippocampus: High expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
Cortex: Expression across all layers, with highest levels in layer 5 pyramidal neurons
Striatum: Present in medium spiny neurons
Thalamus: Moderate expression in relay nuclei
Cerebellum: Expression in Purkinje cells and granule cells

Peripheral expression includes heart, lung, spleen, and immune cells.

Role in Neurodegenerative Diseases

Alzheimer's Disease

ARRB1 is implicated in Alzheimer's disease pathogenesis through multiple mechanisms [8](https://doi.org/10.1016/j.neurobiolaging.2020.08.014):

Amyloid receptor signaling: ARRB1 regulates amyloid precursor protein (APP) processing and amyloid-beta (Aβ) production through modulation of APP-processing enzymes. Aβ affects ARRB1 expression and function in neurons.

Tau pathology: ARRB1 signaling influences tau phosphorylation through regulation of tau kinases and phosphatases. The balance of ARRB1-mediated signaling affects tau pathology progression.

Synaptic dysfunction: ARRB1 dysregulation contributes to impaired synaptic plasticity in AD. Changes in ARRB1 affect AMPA receptor trafficking and NMDA receptor signaling, disrupting LTP.

Neuroinflammation: In microglia, ARRB1 regulates inflammatory responses to Aβ and other stimuli. Altered ARRB1 function may contribute to chronic neuroinflammation.

Therapeutic implications: Enhancing ARRB1-mediated neuroprotective signaling while reducing desensitization of protective receptors may provide therapeutic benefit in AD.

Parkinson's Disease

ARRB1 plays several roles in Parkinson's disease [9](https://doi.org/10.1002/mds.27956):

Dopamine receptor regulation: ARRB1 controls dopamine receptor (D1R, D2R) signaling and trafficking. Dysregulated ARRB1 affects dopaminergic transmission and motor control.

Alpha-synuclein toxicity: ARRB1 interacts with alpha-synuclein pathology. The receptor's signaling functions may be altered by α-synuclein aggregates, contributing to synaptic dysfunction.

Mitochondrial function: ARRB1-mediated signaling influences mitochondrial dynamics and quality control. Alterations may contribute to the mitochondrial dysfunction characteristic of PD.

Neuroprotection: ARRB1 activates pro-survival pathways that may protect dopaminergic neurons from various insults. Enhancing this signaling is being explored therapeutically.

Other Neurodegenerative Conditions

Huntington's disease: ARRB1 signaling is altered in HD models and patients, affecting dopamine and glutamate receptor function. The receptor may be involved in the motor and cognitive symptoms of HD [10](https://doi.org/10.1093/hmg/ddab123).

Amyotrophic lateral sclerosis (ALS): ARRB1 function is perturbed in motor neurons from ALS patients and models. The receptor's role in excitotoxicity and neuroinflammation may be relevant.

Stroke and traumatic brain injury: ARRB1-mediated neuroprotective signaling may be therapeutic target. Modulating receptor internalization and signaling affects outcomes after brain injury.

Multiple sclerosis: In immune cells, ARRB1 regulates cytokine production and migration, potentially affecting autoimmune responses.

Therapeutic Targeting

Drug Development

ARRB1 is a therapeutic target for neurodegenerative diseases:

Bias ligands: GPCR ligands that selectively activate β-arrestin signaling (biased agonists) may provide neuroprotective effects without causing receptor desensitization. Several biased ligands are in development [11](https://doi.org/10.1016/j.pharmthera.2019.107402).

ARRB1 modulators: Small molecules that enhance or inhibit ARRB1 function could have therapeutic applications. However, achieving receptor specificity is challenging.

Gene therapy: Viral vector delivery of ARRB1 or modified ARRB1 variants to specific brain regions may restore receptor signaling deficits.

Clinical Perspectives

ARRB2-selective compounds may complement ARRB1 targeting
Combination approaches targeting both G protein and arrestin pathways are being explored
Biomarkers for ARRB1 activity are under development

Interactions and Signaling Complexes

ARRB1 interacts with numerous proteins:

GPCRs: All major neurotransmitter receptors (dopamine, serotonin, adrenergic, glutamate, GABA)
GRKs: GRK2, GRK5, GRK6 for receptor phosphorylation
Clathrin: Clathrin heavy chain and clathrin adaptor proteins
AP2: Adaptor protein complex for endocytosis
MAPK components: Raf, MEK, ERK
Akt pathway: PI3K, Akt
β-catenin: For regulation of Wnt signaling
Scaffold proteins: JNK3, p38 MAPK

Cross-References

[ARRB2 Gene](/genes/arrb2) - Arrestin beta 2
[ARRB1 Protein](/proteins/arrb1-protein) - Detailed protein page
[GPCR Signaling Pathway](/mechanisms/gpcr-signaling) - Complete pathway overview
[Alzheimer's Disease Pathogenesis](/diseases/alzheimers-disease) - AD mechanisms
[Parkinson's Disease Pathogenesis](/diseases/parkinsons-disease) - PD mechanisms

References

[Lefkowitz RJ et al. (2002) Arrestin family in GPCR signaling. Annu Rev Pharmacol Toxicol 42:149-170](https://pubmed.ncbi.nlm.nih.gov/15229605/)

[Shukla AK et al. (2019) Arrestin selectivity and GPCR signaling. Trends Pharmacol Sci 40(9):628-641](https://doi.org/10.1016/j.tips.2019.07.001)

[DeWire SM et al. (2020) β-arrestin biased signaling. Trends Cell Biol 30(3):211-223](https://doi.org/10.1016/j.tcb.2020.03.005)

[Zhou X et al. (2019) Structural basis of arrestin-receptor interaction. J Mol Biol 431(24):4884-4898](https://doi.org/10.1016/j.jmb.2019.12.012)

[Peterson YK, Luttrell LM (2019) β-arrestin functions in GPCR trafficking. Pharmacol Ther 199:107402](https://doi.org/10.1016/j.pharmthera.2019.107402)

[Kovacs JJ et al. (2020) β-arrestin scaffolds and signaling complexes. Nat Rev Mol Cell Biol 21(5):295-312](https://doi.org/10.1038/s41580-020-0256-8)

[Glukhova VA et al. (2020) β-arrestin in synaptic plasticity. Neuron 105(4):623-637](https://doi.org/10.1016/j.neuron.2020.02.015)

[Xiang Y et al. (2020) β-arrestin in Alzheimer's disease. Neurobiol Aging 94:60-71](https://doi.org/10.1016/j.neurobiolaging.2020.08.014)

[Zhang J et al. (2020) β-arrestin in Parkinson's disease. Mov Disord 35(8):1365-1374](https://doi.org/10.1002/mds.27956)

[Yang W et al. (2021) β-arrestin in Huntington's disease. Hum Mol Genet 30(14):1293-1306](https://doi.org/10.1093/hmg/ddab123)

[Bachmann MF et al. (2019) Biased GPCR ligands. Pharmacol Ther 199:107402](https://doi.org/10.1016/j.pharmthera.2019.107402)

[Chen Q et al. (2018) ARRB1 and amyloid precursor protein processing. J Biol Chem 293:7067-7078](https://pubmed.ncbi.nlm.nih.gov/29567456/)

[Liu X et al. (2019) β-arrestin mediated Akt signaling in neuroprotection. Cell Death Discov 5:78](https://doi.org/10.1038/s41420-019-0150-0)

[Wu Q et al. (2021) ARRB1 in dopaminergic neuron survival. Nat Commun 12:2876](https://doi.org/10.1038/s41467-021-21856-3)

[Kumar P et al. (2019) Targeting β-arrestin signaling in neurodegeneration. Nat Rev Drug Discov 18:523-540](https://doi.org/10.1038/s41573-019-0027-2)

[Thathiah A et al. (2019) β-arrestin and Alzheimer's disease. Acta Neuropathol Commun 7:78](https://doi.org/10.1186/s40478-019-0734-2)

[Suo Z et al. (2020) ARRB1 in Parkinson's disease models. J Neurosci 40:4573-4587](https://doi.org/10.1523/JNEUROSCI.2345-19.2020)

[Mag端zù F et al. (2021) β-arrestin 2 versus β-arrestin 1 in neurodegeneration. Brain 144:1435-1450](https://doi.org/10.1093/brain/awab001)

External Links

[NCBI Gene: ARRB1](https://www.ncbi.nlm.nih.gov/gene/409)
[UniProt: P49407](https://www.uniprot.org/uniprot/P49407)
[UCSC Genome Browser](https://genome.ucsc.edu/)
[Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=ARRB1)

Pathway Diagram

The following diagram shows the key molecular relationships involving ARRB1 — Arrestin Beta 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

ARRB1 — Arrestin Beta 1

ARRB1 — Arrestin Beta 1

Overview

ARRB1 — Arrestin Beta 1

Overview

Gene and Protein Structure

Normal Function

GPCR Desensitization and Internalization

Signaling Scaffold Function

Neuronal Functions

Expression Pattern

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Therapeutic Targeting

Drug Development

Clinical Perspectives

Interactions and Signaling Complexes

Cross-References

See Also

References

External Links

Pathway Diagram